Liver Resection Clinical Trial
— EAGLEOfficial title:
The Effect of Liver Regeneration on Resting Energy Expenditure After Liver Resectional Surgery
This observational study will measure resting energy expenditure in patients who have undergone liver resection and compare methods of measuring resting energy expenditure.
Status | Completed |
Enrollment | 28 |
Est. completion date | September 2014 |
Est. primary completion date | September 2014 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: • Patients undergoing liver resection for benign or malignant hepatic neoplasm Exclusion Criteria: - Inability to give written, informed consent. - Jaundice (Bilirubin > 100 µmol/L) - Liver resection combined with secondary surgical procedure. - Age < 18 years - Pregnant women - Unable to tolerate either measuring device |
Observational Model: Case Control, Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
United Kingdom | Royal Infirmary of Edinburgh | Edinburgh | Lothian |
Lead Sponsor | Collaborator |
---|---|
University of Edinburgh | Royal College of Surgeons of Edinburgh |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Volume of liver resected (g) | Post operative day 1 | No | |
Other | Resting energy expenditure (REE) (Kcal) | 4 weeks post-operative | No | |
Other | Post-operative blood tests (FBC, U&E, LFT, Coag) | Post-operative days 1-7 | No | |
Other | Complications | Day of surgery and post-operative days 1-30 | No | |
Primary | Change in Resting Energy Expenditure (Kcal) following liver resection | 2 weeks pre-operatively and post-operative days 3,5 and 7 | No | |
Secondary | Change in total energy expenditure (Kcal) following liver resection | 2 weeks pre-operatively and post-operative days 3,5 and 7 | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01960049 -
Novel Technique of Analgesia Following Open Liver Resection
|
Phase 4 | |
Terminated |
NCT01921985 -
Terlipressin Administration in Patients Undergoing Major Liver Resection
|
Phase 2 | |
Completed |
NCT01858987 -
Stapler vs. LigaSure in Elective Hepatic Resection
|
N/A | |
Completed |
NCT02834338 -
Enhanced Perioperative Mobilization (EPM) Trial
|
N/A | |
Completed |
NCT02216773 -
Regeneration of Liver: Portal Vein Embolization Versus Radiofrequency Assisted Ligation for Liver Hypertrophy (REBIRTH)
|
N/A | |
Recruiting |
NCT01355887 -
A Trial to Compare Pringle Maneuver With Either Infrahepatic Inferior Vena Cava Clamping or Low Central Venous Pressure
|
Phase 3 | |
Completed |
NCT02056028 -
Bile Leak After Liver Surgery
|
N/A | |
Recruiting |
NCT03917017 -
The Evaluation of Surgical Decisions and Prognosis of the Radiomics and Watson Artificial Intelligence in Patients With Hepatocellular Carcinoma
|
N/A | |
Active, not recruiting |
NCT03904667 -
Application of Watson for Oncology in Hepatocellular Carcinoma Surgery
|
||
Recruiting |
NCT03811704 -
Real-time Navigation for Laparoscope Liver Resections Using Fusion 3D Imaging and Indocyanine Green Fluorescence Imaging
|
Phase 2 | |
Completed |
NCT03171428 -
Hepatectomy With or Without the Thoraco-abdominal Approach
|
N/A | |
Completed |
NCT01770041 -
Paracetamol Metabolism After Liver Surgery
|
N/A | |
Recruiting |
NCT04692259 -
May the Risk of PHLF be Predicted With Preoperative Liver Gadoxetate MRI
|
N/A | |
Active, not recruiting |
NCT03600168 -
Post-Market Clinical Study to Confirm Safety and Performance of PuraStat Absorbable Haemostatic Material for the Management of Bleeding in Liver Surgery
|
||
Recruiting |
NCT04889235 -
Diaphragm Kinetics Following Hepatic Resection
|